Day: August 5, 2025

Invest for Growth Success with First Half New Business Wins of $47 million and Announcement of Organic Investment of $25 million COLUMBUS, Ohio, Aug. 05, 2025 (GLOBE NEWSWIRE) — Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today reports financial and operating results for the fiscal periods ended June 30, 2025. David Duvall, the Company’s President and Chief Executive Officer, said, “I am proud of our team’s disciplined execution in our ability to maintain gross margins with sales being down in our two current major markets: Truck and Powersports,...

Demand Recovery and Strategic Initiatives Drove Revenue Above Expectations Book-to-Bill was Approximately One as Bookings Also Remained Strong MARLBOROUGH, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) — IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the second quarter ended June 30, 2025.  Three Months Ended June 30,           Six Months Ended June 30,        (In millions, except per share data and percentages)   2025       2024       Change       2025       2024       Change  Revenue $ 250.7     $ 257.6       (3 )%   $ 478.5     $ 509.7       (6 )%Gross margin   37.3 %     37.3 %             38.3 %     38.0 %        Operating income $ 0.1     $ 12.0       (99 )%   $ 1.9     $ 31.1       (94 )%Operating margin   — %     4.7 %             0.4 %     6.1 %        Net income $ 6.6     $ 20.2       (67 )%   $ 10.4     $ 44.3       (77 )%Earnings...

Phase 1/2 dose expansion data for Nectin-4 targeting ADC CRB-701 to be presented at ESMO 2025 Initiated 7-day MAD portion of Phase 1 study for obesity drug CRB-913 All three clinical programs (CRB-701, CRB-913, CRB-601) on track for data readouts in the second half of 2025NORWOOD, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage oncology and obesity company, today provided a corporate update and reported financial results for the quarter ended June 30, 2025. “The second half of 2025 is shaping up to be impactful, with scheduled data readouts anticipated for all three of our clinical programs,” said Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. “We have been very pleased with the strong rate of enrollment in the CRB-701 study and...

Second quarter net income of $9.7 millionSecond quarter Adjusted EBITDA of $28.0 millionDredging backlog of $1 billion at June 30, 2025 HOUSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (Nasdaq: GLDD), the largest provider of dredging services in the United States, today reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 HighlightsRevenue was $193.8 million Total operating income was $17.1 million Net income was $9.7 million Adjusted EBITDA was $28.0 million Backlog as of June 30, 2025, was $1.0 billionManagement Commentary Lasse Petterson, President and Chief Executive Officer, commented, “Great Lakes delivered a solid second quarter, driven by strong project execution and high equipment utilization. We ended the quarter...

Reported positive top-line results from SUMMIT evaluating bezuclastinib in patients with NonAdvanced Systemic Mastocytosis, achieving statistical significance across all primary and key secondary endpoints On track to share pivotal trial results from PEAK in GIST and APEX in AdvSM in 2H 2025 $453 million in pro-forma cash sufficient to fund operations through anticipated launch and into 2027; includes proceeds from upsized $230 million public offering in July 2025 WALTHAM, Mass. and BOULDER, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today reported financial results for the second quarter ended June 30, 2025. “We were thrilled to announce bezuclastinib’s impressive performance in the SUMMIT...

2Q 2025 Total revenue grew 18% year-over-year to $54.3 million driven by 35% year-over-year growth in Payor revenue 2Q 2025 Net loss of $0.5 million and adjusted EBITDA1 of $2.3 million 2Q 2025 Share repurchases of $1.4 million NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) — Talkspace, Inc. (“Talkspace” or the “Company”)    (NASDAQ: TALK), today reported second quarter 2025 financial results.    Three Months Ended June 30,     Six Months EndedJune 30,      2025     2024     2025     2024  Unaudited   Results     % Variancefrom PriorYear     Results     % Variancefrom PriorYear  (In thousands unless otherwise noted)                        Number of completed Payor sessions during the period     385.1       29 %     735.1       26 %Number of unique active Payor members during the period     111.2       25 %   N/A     N/A                           Total...

OAK BROOK, Il., Aug. 05, 2025 (GLOBE NEWSWIRE) — Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the one-of-a-kind restaurant concept known for its menu of Chicago-style favorites, today reported financial results for the second quarter ended June 29, 2025. Second Quarter 2025 Performance Highlights (vs. Second Quarter 2024):Total revenue of $188.5 million, an increase of 3.6% or $6.6 million Same-restaurant sales increase of +0.7% Operating income of $17.5 million, a decrease of $0.6 million Net income of $10.0 million, an increase of $1.5 million Restaurant-Level Adjusted EBITDA(1) of $44.5 million, a decrease of $0.1 million Adjusted EBITDA(1) of $30.1 million, an increase of $0.2 million(1) Adjusted EBITDA and Restaurant-Level Adjusted EBITDA are non-GAAP measures. Please see definitions and the reconciliations...

Forward contract cover locked in for 96% of 2025 days and 80% of 2026 daysMaximizing strategic optionality while also returning capital to shareholders via annualized dividend of $2.10 per Class A Common Share ATHENS, Greece, Aug. 05, 2025 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”, “Global Ship Lease” or “GSL”), an owner of containerships, announced today its unaudited results for the three and six-month periods ended June 30, 2025. Second Quarter of 2025 and Year to Date Highlights and Other Recent Developments – 2Q 2025 operating revenue of $191.9 million; up 9.7% on 2Q 2024. 1H 2025 operating revenue of $382.8 million; up 8.0% on 1H 2024. – 2Q 2025 net income available to common shareholders of $93.1 million, or $2.61 Earnings per Share (EPS); up 8.8% on 2Q 2024. 1H 2025 net income available...

Declares Quarterly Cash Dividend of $0.05 Per ShareHighlights          (in million USD, except EPS)   Q2 2025 Q2 2024 6M 2025 6M 2024Net Revenues   $37.5 $43.1 $61.7 $81.4Net income / (loss)   $2.9 $14.1 ($4.0) $24.3Adjusted net income / (loss) 1   $3.8 $16.0 ($1.7) $27.6EBITDA1   $17.4 $25.8 $24.0 $47.4Adjusted EBITDA1   $18.3 $28.0 $26.3 $51.2           Earnings / (loss) per share Basic and Diluted   $0.14 $0.68 ($0.20) $1.18Adjusted earnings / (loss) per share Basic1   $0.18 $0.78 ($0.09) $1.35Adjusted earnings / (loss) per share Diluted1   $0.18 $0.77 ($0.09) $1.34Other Highlights and Developments:Fleet TCE2 of $19,807, a 6% outperformance over the Baltic Capesize Index (“BCI”) Declared $0.05 per share quarterly cash dividend – 15th consecutive quarterly dividend for aggregate cash dividends of...